Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Guillaume Dachy

CAR-T cell outcomes in patients with comorbidities

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Impact of body mass index on outcome of CART cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Survey on the use of SGLT2 inhibitors in cell therapy including autologous and allogeneic hematopoietic stem cell transplantation and CART cell therapy

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Steroid-free first line treatment of moderate and severe chronic GVHD - restrospective study

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Effects of donor clonal hematopoiesis in unrelated HSCT

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

F. Damm & J. Schetelig

Treatment Related and population mortality for Older Patients (TROP)

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Johannes Schetelig; Liesbeth de Wreede‬

Outcomes and risk factors for survival of lung transplantation after allogeneic HSCT

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Juan Montoro Gomez; Saskia Bos

Secondary autoimmune and inflammatory diseases (sec.AIID) post allogeneic HSCT

Retrospective Studies

Complications Working Party (CWP)

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Arsene Mekinian

Graft rejection in haploidentical HSCT: survey of subsequent therapeutic options

Closed Survey/Study

Complications Working Party (CWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Nadira Durakovic

Machine Learning grading system for acute graft-versus host disease

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Steroid refractory acute graft-versus-host disease - survey

Complications Working Party (CWP)

Type de traitement

Investigateur principal